Delivery Order SPE2DB20D3103-SPE2DB25FQ3U4
- Not listed
- The Defense Logistics Agency awarded a $1,912.24 delivery order to AmerisourceBergen Drug Corp for Uloric 40 mg tablets (30-count) on September 19, 2025, with a completion date of September 22, 2025. This competitively awarded, firm fixed-price contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The prime vendor agreement serves as a comprehensive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,580.18 to AmerisourceBergen Drug Corp for the supply of Uloric 80 mg tablets (30-count units) under a firm fixed-price contract type. The award was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and is classified as a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Uloric 80 mg tablets (30-count packages) under a firm fixed-price contract valued at $18,138.23, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside delivery order represents a continuation of the company's pharmaceutical supply relationship with DLA and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 19, 2025, for the supply of Uloric 80 mg tablets in quantities of 30 units under a firm fixed-price contract with a ceiling value of $2,424.82. This non-set-aside delivery order is scheduled for completion by May 20, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Uloric is a branded pharmaceutical used primarily in the treatment of chronic gout,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,039.85, is for the delivery of Uloric 40 mg tablets. The contract is a firm-fixed-price, Indefinite Delivery Contract (IDC) that runs through August 15, 2022. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has no set-aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ULORIC 40 MG TABLET 30S. The order, valued at $3,321.78, is a firm fixed-price contract with an ultimate completion date of October 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ULORIC 40 MG TABLET 30S. The fixed-price contract has a ceiling value of $2,077.25 and runs through November 2023. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has no set-aside designation, indicating open competition. This delivery order is likely part of a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564450183 ULORIC 40 MG TABLET 30S. The $2,802.33 firm-fixed-price contract has a completion date of May 1, 2024 and was awarded on April 30, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,155.59, is for the delivery of ULORIC 40 MG TABLET 30S, a medication used to treat gout. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,158.48 firm fixed-price delivery order is for the supply of ULORIC 80 MG TABLET 30S, a generic pharmaceutical product. The contract has a completion date of June 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3U4Delivery Order
This delivery order, valued at $4,433.81, represents a competitive award by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Uloric 40 mg tablets (30-count packaging). The award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and employs firm fixed pricing with no set-aside designation. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support mechanism enabling the supply of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated consistent capability in meeting federal medical procurement requirements through competitive awards across multiple therapeutic domains, making it a critical vendor for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 9/18/25 |